Holen Sie sich die Stockscreener-App
17.96
6.08%
1.03
Vorhandelsmarkt:
17.57
-0.39
-2.17%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TEVA?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$16.93
Offen:
$17.25
24-Stunden-Volumen:
19.40M
Relative Volume:
1.63
Marktkapitalisierung:
$18.80B
Einnahmen:
$16.54B
Nettoeinkommen (Verlust:
$-1.64B
KGV:
-12.39
EPS:
-1.45
Netto-Cashflow:
$749.00M
1W Leistung:
+9.58%
1M Leistung:
+33.43%
6M Leistung:
+4.97%
1J Leistung:
+10.52%
1-Tages-Spanne:
$16.90
$18.07
1-Wochen-Bereich:
$16.12
$18.30
52-Wochen-Spanne:
$12.46
$22.80
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile
Firmenname
Teva Pharmaceutical Industries Ltd Adr
Sektor
Telefon
972 (3) 914-8213
Adresse
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Vergleichen Sie TEVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.96 | 18.80B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ZTS
Zoetis Inc
|
161.92 | 70.37B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.19 | 48.41B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
10.71 | 47.91B | 14.35B | 1.85B | 0 | 0.4023 |
|
UTHR
United Therapeutics Corp
|
310.80 | 13.47B | 2.76B | 1.11B | 898.10M | 22.77 |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-10 | Hochstufung | Argus | Hold → Buy |
| 2024-03-08 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-12 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-01-23 | Hochstufung | Jefferies | Hold → Buy |
| 2024-01-03 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-11-27 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-06 | Hochstufung | UBS | Sell → Neutral |
| 2023-05-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-01-19 | Herabstufung | Jefferies | Buy → Hold |
| 2022-11-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-11-04 | Herabstufung | UBS | Neutral → Sell |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-08-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-06-14 | Fortgesetzt | UBS | Neutral |
| 2022-05-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-04 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2022-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-03-25 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-01-27 | Herabstufung | Argus | Buy → Hold |
| 2021-10-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-05-04 | Herabstufung | UBS | Buy → Neutral |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-25 | Eingeleitet | Oppenheimer | Perform |
| 2020-08-06 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2020-07-27 | Fortgesetzt | Goldman | Neutral |
| 2020-06-01 | Hochstufung | SunTrust | Hold → Buy |
| 2020-04-24 | Fortgesetzt | Citigroup | Neutral |
| 2020-04-06 | Hochstufung | UBS | Neutral → Buy |
| 2020-02-24 | Herabstufung | Edward Jones | Hold → Sell |
| 2019-11-12 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-10-17 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2019-08-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-07-19 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2019-07-10 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-07-05 | Hochstufung | Argus | Hold → Buy |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-06-03 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2019-05-30 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-05-28 | Herabstufung | UBS | Buy → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-03-07 | Fortgesetzt | UBS | Buy |
Alle ansehen
Teva Pharmaceutical Industries Ltd Adr Aktie (TEVA) Neueste Nachrichten
Why Teva Pharmaceuticals Stock Blasted 6% Higher Today - The Motley Fool
Teva Earnings: Innovation Propels Sales and Generics Show Stability in Solid Start to the Year - Morningstar
Teva and Alvotech stocks jump on FDA approval of SELARSDI By Investing.com - Investing.com South Africa
Teva and Alvotech stocks jump on FDA approval of SELARSDI - Investing.com Australia
There Are Mixed Signals on the Chart for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - uspostnews.com
Digi Power X Inc (DGXX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Market Analysts see Norwegian Cruise Line Holdings Ltd [NCLH] gaining to $21. Time to buy? - dbtnews.com
PG&E Corp [PCG] Revenue clocked in at $24.54 billion, down -14.37% YTD: What’s Next? - dbtnews.com
Greenwave Technology Solutions Inc [GWAV] Is Currently 12.13 above its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Performance and Fundamentals Dashboard tells a completely different story – Sete News - Sete News
Raymond James slashes price target on Adma Biologics Inc [ADMA] – find out why. - dbtnews.com
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: A Year of Highs and Lows - investchronicle.com
Company’s Banking Stock: Dissecting a 37.52% Quarterly Revenue Decline Amid Growth - investchronicle.com
NEOV’s Market Whiplash: -48.46% YTD Decline, 15.24% Rise in 30 Days - investchronicle.com
Adagio Medical Holdings Inc (ADGM) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com
A company insider recently sold 70,961 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]. Should You Sale? - knoxdaily.com
Introducing Our Rant Against Teva- Pharmaceutical Industries Ltd. ADR - uspostnews.com
OS overperforms with a 2.12 increase in share price - uspostnews.com
For Kopin Corp [KOPN], Analyst sees a rise to $2. What next? - dbtnews.com
Market Analysts see Geron Corp [GERN] falling to $2. Time to buy? - dbtnews.com
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.18 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com
The growth track for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has changed recently - Sete News
Rezolute Inc: Weathering Stock Market Storms with 190.08M Market Cap - investchronicle.com
Ready to Jump After Recent Trade: NIO Inc ADR (NIO) - Sete News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com
ORCL’s Stock Journey: What Investors Need to Know About Oracle Corp’s Performance - investchronicle.com
TGB Stock Update: Taseko Mines Ltd’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
Lexicon Pharmaceuticals Inc (LXRX) Stock: A Year of Market Fluctuations - investchronicle.com
HESM’s latest rating updates from top analysts. - knoxdaily.com
Analysts review Teva- Pharmaceutical Industries Ltd. ADR’s rating - knoxdaily.com
Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com
Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com
What technical indicators reveal about MYGN stock - uspostnews.com
VF Corp (VFC) is a good investment, but the stock may be overvalued - uspostnews.com
Investing in Calumet Inc (CLMT) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
Wabash National Corp (WNC) stock on the rise: An overview - uspostnews.com
The Gryphon Digital Mining Inc (GRYP) had a good session last reading, didn’t it? - uspostnews.com
Generics Industry: India Celebrates Pharmaceutical Tariffs Exemption but Uncertainty Remains High - Morningstar
What will the future hold for CarGurus Inc (NASDAQ:CARG) stock? - US Post News
TEVA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Teva Pharmaceutical Stock Scores RS Rating Upgrade - MSN
IBD Rating Upgrades: Teva Pharmaceutical ADR Flashes Improved Relative Price Strength - Investor's Business Daily
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
How does TEVA’s price to cash per share ratio compare in the market? - US Post News
Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire
Validea Detailed Fundamental AnalysisTEVA - Nasdaq
Why weight-loss drugs are the top target of Medicare price negotiations - Equities News
Investor Network: Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire
Is the SM Energy Co (NYSE:SM) stock an investment opportunity? - US Post News
Teva Pharmaceutical Stock: Strategic Global Access Initiatives Advance - sharewise
Are Clear Secure Inc’shares a good deal? - US Post News
Finanzdaten der Teva Pharmaceutical Industries Ltd Adr-Aktie (TEVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.11%
2.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):